P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models

Neuroblastoma (Peripheral neuroblastic tumours)

(2016) Roberto Luksch et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts

(2016) N. E. Chen et al.   MOLECULAR CANCER THERAPEUTICS

Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations

(2015) Kristopher R. Bosse et al.   CANCER

Abstract 2616: Comparison of the cytotoxicity and increase of reactive oxygen species and dihydroceramides of fenretinide to its major metabolites (4-oxo- and 4-methoxyphenyl fenretinide) in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines

(2015) Michael M. Song et al.   CANCER RESEARCH

Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations

(2014) Ahsan S. Farooqi et al.   JOURNAL OF NEURO-ONCOLOGY

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: A report from the new approaches to neuroblastoma therapy (NANT) consortium

(2013) Barry J. Maurer et al.   PEDIATRIC BLOOD & CANCER

Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure

(2011) Jason P Cooper et al.   BRITISH JOURNAL OF PHARMACOLOGY

Phase II Study of Oral Capsular 4-Hydroxyphenylretinamide (4-HPR/Fenretinide) in Pediatric Patients with Refractory or Recurrent Neuroblastoma: A Report from the Children's Oncology Group

(2011) J. G. Villablanca et al.   CLINICAL CANCER RESEARCH

Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma

(2011) H. Fang et al.   CLINICAL CANCER RESEARCH

Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases

(2010) NA Illingworth et al.   BRITISH JOURNAL OF PHARMACOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma

(2009) Roos Cuperus et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL

The xenobiotic inhibitor profile of cytochrome P4502C8

(2003) Chin-Eng Ong et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY